SCHEMBL2303697

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL10173615	0.89	PTGES (0.45)	PTGESNR3C1NPC1RAB9ASMN1; SMN2
	SCHEMBL2696597	0.88	PTGES (0.46)	PTGESRAF1BRAFNPC1RAB9A
	SCHEMBL10173606	0.86	PTGES (0.37)	PTGESRAF1BRAFP2RX3PDE4A
	SCHEMBL2683882	0.86	PTGES (0.42)	PTGESNR3C1RAF1BRAFNPC1
	SCHEMBL2699731	0.84	PTGES (0.55)	PTGES
	SCHEMBL2699538	0.81	PTGES (0.38)	PTGES
	SCHEMBL10173654	0.79	PTGES (0.48)	PTGESNPC1
	SCHEMBL2359367	0.78	PTGES (0.47)	PTGESNPC1RAB9ASMN1; SMN2
	SCHEMBL2686479	0.77	PTGES (0.55)	PTGES
	SCHEMBL2685743	0.77	PTGES (0.48)	PTGESNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.